Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elective hysterectomy. Benefits, risks, and costs.

S I Sandberg, B A Barnes, M C Weinstein

    Medical Care
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Harvard-MIT-NEMC Research Training Program in Medical Informatics.

    Yearbook of medical informatics·2016
    Same author

    Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
    Same author

    Patent vitelline duct.

    Medical bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon·2010
    Same author

    The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.

    HIV medicine·2007
    Same author

    Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2006
    Same author

    Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States.

    Vox sanguinis·2004

    Hysterectomy offers improved life expectancy and quality of life for women aged 30-60 by preventing cancers, outweighing surgical risks. However, risks increase for those with high operative risk or younger women not on estrogen replacement therapy.

    Area of Science:

    • Gynecologic Oncology
    • Reproductive Medicine
    • Health Economics

    Background:

    • Hysterectomy is a common surgical procedure for various gynecological conditions.
    • The long-term impacts of hysterectomy on life expectancy and quality of life require comprehensive evaluation.
    • Decision analysis models can integrate complex data to assess health outcomes.

    Purpose of the Study:

    • To compare hysterectomy (with or without oophorectomy) versus medical management.
    • To evaluate effects on life expectancy, quality of life, and medical costs.
    • To identify patient subgroups benefiting or losing from hysterectomy.

    Main Methods:

    • Decision analysis techniques were employed.
    • Data on sequelae and operative mortality were utilized.

    Related Experiment Videos

  • Sensitivity analyses were performed to determine risk thresholds.

    • Main Results:

    • Women aged 30-60 undergoing hysterectomy for specific benign conditions showed gains in life expectancy and quality of life, primarily due to cancer prevention.
    • High operative risk or low expected cancer risk can lead to net losses in life expectancy.
    • Younger women (<35) without estrogen replacement after hysterectomy and oophorectomy face reduced life expectancy due to increased cardiovascular and osteoporosis risks.
    • Sterilization is a significant quality of life consideration for women desiring future fertility.

    Conclusions:

    • Hysterectomy can be beneficial for women aged 30-60 with specific gynecological conditions, balancing surgical risks against cancer prevention.
    • Careful patient selection is crucial, considering individual risk factors and long-term health implications.
    • Hormone replacement therapy is essential for younger women undergoing oophorectomy to mitigate long-term health risks.